Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
COLACE EXTRA STRENGTH STOOL SOFTNER Docusate Sodium 250 mg Capsule, Liquid Filled — NDC 67618-201-12 (Billing 67618-0201-12)
by Atlantis Consumer Healthcare Inc. · 2 BOTTLE in 1 PACKAGE / 60 CAPSULE, LIQUID FILLED in 1 BOTTLE
This is a package of COLACE EXTRA STRENGTH STOOL SOFTNER Docusate Sodium 250 mg Capsule, Liquid Filled from Atlantis Consumer Healthcare Inc., marketed since Aug 2024 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.
NDC 67618-0201-12
🏷️ FDA NDC (as labeled)
67618-201-12
billing pads the product segment with a zero
This package
Contains60 capsule, liquid filled in 1 bottle
Pack sizes2 compare ↓
Main listing for product 67618-201 · Also comes in:
60 capsules 67618-201-60
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 67618-201-12 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 67618 labeler · 201 product · 12 package
- Package marketed since
- Jul 1, 2025
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC)
- 0367618000175
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
67618-201-12
Product NDC
67618-201
11-digit billing NDC
67618020112
UNII
F05Q2T2JA0
UPC
0367618000175
Application #
M007
SPL Set ID
34e06b05-64a5-4b3e-af38-cdcd7c1d521b
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-08-05
Route
ORAL
Dosage form
CAPSULE, LIQUID FILLED
Substance
DOCUSATE SODIUM
Quick answers
- RxCUI (RxNorm): 1245468
Why two NDCs?
The FDA registers this code as 67618-201-12 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 67618-0201-12. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Softeners, emollients class.
Drug family (ATC)
Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
📖 About the active ingredient: Docusate Sodium MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
Read the full MedlinePlus article ↗🧪 What is this product?
Colace Extra Strength Stool Softener is an over-the-counter oral capsule containing 250 mg of docusate sodium. Docusate sodium is a stool softener typically used to make bowel movements easier and less straining by helping the stool retain moisture. This product is marketed under the FDA's monograph rules for over-the-counter digestive aids rather than through individual drug approval.
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Docusate Sodium — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 5, 2026
💬 Questions about Docusate Sodium?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size:
60 capsules
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 5, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 67618-0201-12 You're viewing this Main listing | 2 BOTTLE in 1 PACKAGE / 60 CAPSULE, LIQUID FILLED in 1 BOTTLE | 2025-07-01 | — | Active |
| 67618-0201-60 67618-201-60 | 60 CAPSULE, LIQUID FILLED in 1 BOTTLE | 2024-08-05 | — | Active |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 2 bottle in 1 package / 60 capsule, liquid filled in 1 bottle.
What NDC number is used to bill for this package of COLACE EXTRA STRENGTH STOOL SOFTNER Docusate Sodium 250 mg Capsule, Liquid Filled?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Stool Softener Laxative 250 mg 00904-7281-60 | Major | 100 capsules | $0.052 | — | Availability likely | — |
| Good Neighbor Stool Softener laxative 250 mg 46122-0693-78 | AmerisourceBergen | 100 capsules | $0.052 | — | Availability likely | — |
| Stool Softener 250 mg 46122-0826-74 | Amerisource | 100 capsules | $0.052 | — | Availability likely | — |
| Docusate Sodium 250 mg 50268-0268-15 | AvPAK | 1 capsule | $0.052 | — | Availability likely | — |
| Stool Softener 250 mg 70677-1096-01 | Strategic | 100 capsules | $0.052 | — | Availability likely | — |
| Preferred Stool Softener laxative 250 mg 10956-0781-00 | Reese | 140 capsules | — | — | FDA listed | — |
| Stool Softener Laxative 250 mg 17856-7281-01 | ATLANTIC | 1 capsule | — | — | FDA listed | — |
| Stool Softener Laxative Extra Strength 250 mg 36800-0568-10 | TOP | 100 capsules | — | — | Discontinued | — |
| Stool Softener 250 mg 36800-0640-10 | TOP | 100 capsules | — | — | FDA listed | — |
| H E B Stool Softener laxative 250 mg 37808-0293-88 | H | 140 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 37808-0585-14 | HEB | 140 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 37808-0879-14 | H | 140 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 37835-0223-01 | Bi-Mart | 100 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 41250-0859-10 | MEIJER, | 100 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 49035-0378-14 | EQUATE | 140 capsules | — | — | Discontinued | — |
| Prolaxa 250 mg 53225-2001-01 | Terrain | 100 capsules | — | — | FDA listed | — |
| Docusate Sodium 250 mg 53345-0035-01 | Humanwell | 7000 capsules | — | — | FDA listed | — |
| Docusate Sodium 250 mg 54629-0601-01 | National | 100 capsules | — | — | FDA listed | — |
| Docusate Sodium 250 mg 55154-4341-00 | Cardinal | 1 capsule | — | — | Discontinued | — |
| Stool Softener Extra Strength 250 mg 55910-0879-10 | Dolgencorp, | 100 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 57896-0426-01 | Geri-Care | 100 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 59726-0058-25 | P | 250 capsules | — | — | FDA listed | — |
| Stool Softener Laxative Extra Strength 250 mg 59726-0059-10 | P | 100 capsules | — | — | FDA listed | — |
| Stool Softener Laxative Extra Strength 250 mg 59726-0879-10 | P | 100 capsules | — | — | FDA listed | — |
| Quality Choice Stool Softener laxative 250 mg 63868-0662-01 | Chain | 100 capsules | — | — | FDA listed | — |
| Colace Extra Strength Stool Softner 250 mgthis 67618-0201-12 | Atlantis | 60 capsules | — | — | FDA listed | — |
| Stool Softener Laxative 250 mg 68016-0471-01 | Chain | 100 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 68016-0587-00 | Chain | 100 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 68071-5297-06 | NuCare | 60 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 69842-0740-25 | CVS | 250 capsules | — | — | FDA listed | — |
| Stool Softener Extra Strength 250 mg 69842-0879-25 | CVS | 250 capsules | — | — | FDA listed | — |
| Stool Softener 250 mg 71335-1677-01 | Bryant | 30 capsules | — | — | FDA listed | — |
| Docusate Sodium 250 mg 72789-0166-60 | PD-Rx | 60 capsules | — | — | FDA listed | — |
| Topcare Stool Softener laxative 250 mg 76162-0764-10 | TOPCO | 100 capsules | — | — | FDA listed | — |
| Stool Softener Laxative Extra Strength 250 mg 79903-0073-14 | WALMART | 140 capsules | — | — | FDA listed | — |
| Prolaxa 250 mg 80425-0540-01 | Advanced | 100 capsules | — | — | FDA listed | — |
| Docusate Sodium, Extra Strength 250 Mg 80513-0100-01 | Advanced | 100 capsules | — | — | FDA listed | — |
| Docusate Sodium, Extra Strength 250 Mg 80513-0101-01 | Advanced | 100 capsules | — | — | FDA listed | — |
| Stool Softener Laxative 250 mg 71335-2313-01 | Bryant | 30 capsules | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2024
On the market since
Aug 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
What it looks like
Color
white
ShapeOval
ImprintC250
Size12 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
- FDA label on DailyMed · label index refreshed Oct 5, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 68401960MK
Crospovidone is a synthetic polymer made from polyvinylpyrrolidone. It acts as a disintegrant, helping tablets break apart quickly in the stomach so the medicine dissolves and absorbs into the body.
-
UNII 2G86QN327L
Gelatin is a protein derived from animal collagen, commonly used in medicines as a gelling agent and capsule material. It helps create soft or hard capsule shells that hold and release medication, and can also thicken liquid formulations.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII 3WJQ0SDW1A
Polyethylene glycol is a synthetic liquid or solid polymer used in medicines as a solvent, lubricant, and humectant. It helps dissolve active ingredients, reduces friction during manufacturing, and retains moisture in the final product.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 506T60A25R
Sorbitol is a natural sugar alcohol derived from glucose. It serves as a sweetener, humectant, and bulking agent in medications to improve taste and help maintain moisture in the product.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
7 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesgelatin, glycerin, polyethylene glycol, povidone, propylene glycol, purified water, sorbitol. Softgels are imprinted with edible, dye-free ink.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 5, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerAtlantis Consumer Healthcare Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code67618
First marketedAug 2024
Product typeHuman Otc Drug
More NDCs from Atlantis Consumer Healthcare Inc. labeler code 67618
- Betadine Gargle POVIDONE-IODINE .05 mg/mL Solution NDC 67618-181-08
- Maximum Strength Betadine Clear Benzalkonium Cl and Pramoxine HCl .13 mg/mL; 1 mg/mL Spray NDC 67618-183-06
- Betadine Foam Cleanser Benzalkonium Chloride .13 g/100mL Aerosol, Foam NDC 67618-184-08
- Betadine POVIDONE-IODINE 100 mg/mL Solution NDC 67618-190-01
- Betadine POVIDONE-IODINE 5 mg/mL Spray NDC 67618-192-03
- BETASEPT Antiseptic Surgical Scrub .04 mg/mL Solution NDC 67618-200-04
- Senokot standardized senna concentrate 8.6 mg Tablet NDC 67618-300-10
- Senokot-S standardized senna concentrate and docusate sodium 50 mg; 8.6 mg Tablet NDC 67618-310-01
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
📦 Storage and Handling
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Keep Out of Reach of Children
📄 Questions or Comments
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses relieves occasional constipation (irregularity) • generally produces a bowel movement within 12 to 72 hours.
⏱️ Dosage and Administration ▾
Directions adults and children 12 years of age and older take 1 softgel daily or as directed by a doctor. children under 12 years of age ask a doctor
⚠️ Warnings ▾
Warnings Do not use if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if you have Stomach pain Nausea Vomiting Noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These can be signs of a serious condition you need to use a stool softner laxative for more than 1 week If pregnant or breast-feeding , ask a health care professional before use.
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center immediately.
📦 Storage and Handling ▾
Other information each softgel contains: sodium 15mg store at 20-25°C (68-77°F). Keep carton for full product information
🧪 Active Ingredient ▾
Active ingredient (in each softgel) Docusate Sodium 250 mg
🧪 Inactive Ingredients ▾
Inactive ingredients gelatin, glycerin, polyethylene glycol, povidone, propylene glycol, purified water, sorbitol. Softgels are imprinted with edible, dye-free ink.
🎯 Purpose ▾
Purpose Stool softener
📄 Keep Out of Reach of Children ▾
Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center immediately.
📄 Questions or Comments ▾
Questions? 1-833-288-2684
📄 Package Label / Principal Display Panel ▾
Principal Display Panel EXTRA STRENGTH #1 DOCTOR RECOMMENDED Stool Softner Brand COLACE Docusate Sodium, 250mg EXTRA STRENGTH Stool Softner √Gentle & Effective √Relieves Constipation √Cramp & Stimulant-Free √Dye & Preservative-Free √ 60 Clear Soft Gels Retain this carton for important information. Dis. By: Atlantis Consumer Healthcare Inc.
Bridgewater, NJ 08807 USA Questions? 1-833-288-2684 ©2024 Atlantis Consumer Healthcare Inc. Colace is a registered trademark of Atlantis Consumer Healthcare Inc.
A0824 Colace Extra strength 250mg 60 softgels
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Docusate Sodium — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 41%
Female · 59%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Atlantis Consumer Healthcare Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 60 capsules (67618-0201-60). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Atlantis Consumer Healthcare Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.